Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3Sbio, Adagio, Albany Molecular Research, Almac, Asahi Kasei, Ascletis, Aum Biosciences, Bintai Kinden, Changchun High-Tech Industry, China Biologic Products, Curevac, Eli Lilly, F4, Foresee, Fresenius Kabi, Generex, Generex, Hifibio, Imanis Life Sciences, Immunoprecise Antibodies, Insel Gruppe, Insilico Medicine, Medivir, Merck, Metavant Sciences, Moderna, Mymetics, Newsoara, Ology Bioservices, Pharming, Pharmsynthez, Pierre Fabre, Poxel, Probiogen, Relief, Roivant Sciences, Samsung Biologics, Selecta Biosciences, Sosei, Sotira, Sumitomo Dainippon, Syneos Health, Syngene International, Twist Bioscience, Vifor, Vifor Fresenius Medical Care Renal, Wacker Chemie, Xbiotech, Y-biologics.